Amendment in Export Policy of Injection Remdesivir and Remdesivir API - 08/2015-2020 - Foreign Trade Policy

Government of India Ministry of Commerce Industry Department of Commerce Directorate General of Foreign Trade Udyog Bhawan New Delhi Notification No. 08/2015-2020 New Delhi, Dated: 14 June, 2021 Subject: Amendment in Export Policy of Injection Remdesivir and Remdesivir API. S.O. 2332 (E) - In exercise of powers conferred by Section 3 of the Foreign Trade (Development Regulation) Act, 1992 (No. 22 of 1992) , as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby amends the Notification No. 01/2015-20 dated 11.04.2021 related to export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) : S. No. ITC HS Codes Description Present Policy Revised Policy 207AA Ex 293499 Ex 300490 Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) Prohibited Restricted 2. The export of Remdesivir Injections/API against the Advance Authorizations issued under Chapter 4 of FTP /HBP shall not require a separate export authorisation or permission. 3. Effect of this Notification: The export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) falling under the ITC (HS) Codes specified above or falling under any other HS Code has been put under Restricted category with immediate effect. The export of Remdesivir Injections/API against the Advance Authorizations will not require a separate authorisation/ permission. (AMIT YADAV) Director General of Foreign Trade Ex-Officio Addl. Secy. GOI Email [email protected] [ Issued from F. No. 01/91/180/24/AM-22/EC/E-27724]